11 new COVID-19 cases in Quad County area Tuesday

Carson City Health and Human Services reported 11 new cases and 20 additional recoveries of COVID-19 in the Quad-County Region on Tuesday.
This brings the total number of cases to 12,535, with 11,939 recoveries and 225 deaths; 371 cases remain active.

Total Cases 

Active Cases

Recoveries

Deaths

*Population

Carson City

6,448

158

6,168

122

56,546

Douglas County

2,822

82

2,705

35

49,695

Lyon County

3,160

120

2,975

65

57,987

Storey County

105

11

91

3

4,465

Quad-County

12,535

371

11,939

225

168,693

*Population information taken from the Nevada Health Response Dashboard found at https://nvhealthresponse.nv.gov/

Janssen COVID-19 Vaccination Clinics
 
There are upcoming Janssen COVID-19 vaccination clinics. Schedule your appointment at https://booking.appointy.com/en-US/quadcovidvaccine/bookings/service.
  • Thursday, May 6, 2021 | 12 p.m. to 12:45 p.m.
    • Douglas County Fairgrounds (Pinenut Rd, Gardnerville)
    • 200 appointments available
  • Wednesday, May 12, 2021 | 12 p.m. to 2 p.m.
    • Dayton Calvary Baptist Church (4 Flowery Ave, Dayton)
    • 150 appointments available
  • Wednesday, May 12, 2021 | 12:30 p.m. to 3 p.m.
    • Fuji Park (701 Old Clear Creek Rd, Carson City)
    • 300 appointments available
 
Drive-Thru COVID-19 Testing for Quad-County Residents 
Testing is for Quad-County (Carson City, Douglas, Lyon, and Storey County) residents ONLY, all others will be turned away. Testing is free of charge, no appointments or reservations. To view all upcoming events visit https://gethealthycarsoncity.org/events/.

Date

Time

Location

5/5/2021

9 a.m. to 10:30 a.m.

Douglas Community Center

1329 Waterloo Ln, Gardnerville

5/6/2021

10 a.m. to 11:30 a.m.

Fernley City Hall

595 Silver Lace Blvd, Fernley

For COVID-19 questions, vaccine appointment assistance, or to arrange for testing, call the Quad-County COVID-19 Hotline Monday through Friday, 8:30 am to 4:30 pm. The phone number is (775) 434-1988.

Comments

Use the comment form below to begin a discussion about this content.

Sign in to comment